Cargando…
Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences
BACKGROUND: Retinal endothelial cells are crucially involved in the genesis of diabetic retinopathy which is treated with vascular endothelial growth factor (VEGF) inhibitors. Of these, ranibizumab can completely restore VEGF-induced effects on immortalised bovine retinal endothelial cells (iBREC)....
Autores principales: | Deissler, Heidrun L, Deissler, Helmut, Lang, Gabriele E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382447/ https://www.ncbi.nlm.nih.gov/pubmed/22539748 http://dx.doi.org/10.1136/bjophthalmol-2012-301677 |
Ejemplares similares
-
Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells
por: Deissler, Heidrun L., et al.
Publicado: (2013) -
Fate of the Fc fusion protein aflibercept in retinal endothelial cells: competition of recycling and degradation
por: Deissler, Heidrun L., et al.
Publicado: (2018) -
Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells
por: Deissler, Heidrun L., et al.
Publicado: (2015) -
Sitagliptin and the Blood-Retina Barrier: Effects on Retinal Endothelial Cells Manifested Only after Prolonged Exposure
por: Jäckle, Anja, et al.
Publicado: (2020) -
Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitro
por: Deissler, Heidrun L., et al.
Publicado: (2022)